St. Cloud, MN – (December 11, 2024) Lathrop GPM advised Microbiologics, a biotechnology company focused on infectious disease reference materials and contract research services, in its acquisition of SensID, a manufacturer of reference materials and quality controls for molecular diagnostics in oncology and precision medicine.
Founded in 2015, SensID is based in Rostock, Germany. The acquisition was announced November 6.
This acquisition expands Microbiologics’ reach into the field of oncology and precision medicine, while continuing its leadership in infectious disease diagnostics. SensID will continue operations at its Germany headquarters, which will represent Microbiologics’ first location outside of the United States.
Lathrop GPM’s team advising Microbiologics was led by partner Ryan Gerads.